Cyclophosphamide and Citrobacter sepsis - a phase IV clinical study of FDA data

Summary:

Citrobacter sepsis is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are male, 50-59 old, also take Dexamethasone, and have B precursor type acute leukaemia.

The phase IV clinical study analyzes which people have Citrobacter sepsis when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Citrobacter sepsis?

Citrobacter sepsis (infection by citrobacter (bacteria) in blood) is found to be associated with 17 drugs and 23 conditions by eHealthMe. Check the latest studies of Citrobacter sepsis.

On Jul, 05, 2026

185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 12 people (0.01%) have Citrobacter sepsis.

Could Cyclophosphamide cause Citrobacter sepsis?

Among these 12 people:

What is the gender of people who have Citrobacter sepsis when taking Cyclophosphamide? *

female: 0.0 %
male: 100 %

What is the age of people who have Citrobacter sepsis when taking Cyclophosphamide? *

What are other drugs people take besides Cyclophosphamide? *

What are other side effects people have besides Citrobacter sepsis? *

Bone Marrow Failure: 7 people, 58.33%
Pseudomonal Sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas): 7 people, 58.33%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 7 people, 58.33%
Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 7 people, 58.33%
Molluscum Contagiosum (a viral infection of the skin or occasionally of the mucous membranes): 7 people, 58.33%
Gangrene (body tissue dies): 7 people, 58.33%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 58.33%
Streptococcal Infection: 7 people, 58.33%
Blood Fibrinogen Decreased: 4 people, 33.33%
Mucosal Inflammation (infection of mucous membrane): 4 people, 33.33%

What are the existing conditions these people have? *

Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 4 people, 33.33%
B Precursor Type Acute Leukaemia (lymphoid cancer): 4 people, 33.33%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 2 people, 16.67%
Bacterial Infection: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and have Citrobacter sepsis?

- Check whether Citrobacter sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:

Cyclophosphamide (185,240 reports)

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Citrobacter sepsis:

Citrobacter sepsis (17 drugs)

Browse all the conditions that are associated with Citrobacter sepsis:

Citrobacter sepsis (23 conditions)

Related publications that referenced our studies

Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.